How is NGS, identification of microsatellite instability and mismatch repair defects, and molecular target stratification that comprehensive genomic profiling improving management of prostate cancer?

How is NGS, identification of microsatellite instability and mismatch repair defects, and molecular target stratification that comprehensive genomic profiling improving management of prostate cancer?

How is NGS, identification of microsatellite instability and mismatch repair defects, and molecular target stratification that comprehensive genomic profiling improving management of prostate cancer?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Prof. Johann De Bono, MD, PhD

Prof. Johann De Bono, MD, PhD

Professor of Experimental Cancer Medicine
Honorary Consultant Medical Oncologist
Royal Marsden Hospital
Head of the Division of Clinical Studies
Institute of Cancer Research
London, UK